de Koert Jong
University of Groningen
18 Papers
198 Citations
de Koert Jong is an academic researcher from University of Groningen. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 10, co-authored 18 publications.
Chat about Author
Papers
Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
Joost Hof,M W J L A E Wertenbroek,P. M. J. G. Peeters,Joachim Widder,Egbert Sieders,de Koert Jong +5 more
TL;DR: The aim of this study was to analyse survival rates with radiofrequency ablation as an alternative for unresectable CRLMs in patients with repeat liver resection for colorectal liver metastases.
131
Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors
de Koert Jong,R Stellema,Arend Karrenbeld,J Koudstaal,Annette S. H. Gouw,Willem Sluiter,Pmjg Peeters,Maarten J.H. Slooff,de Elisabeth G. E. Vries +8 more
TL;DR: In patients with colorectal liver metastases, referred for liver surgery, a higher TGF‐α expression is associated with unfavorable tumor characteristics, whereas p53 and absence of EGFr expression isassociated with a better survival after partial liver resection.
126
The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection.
Annette S. H. Gouw,M. C. van den Heuvel,van den Arie Berg,Njh Slooff,de Koert Jong,Sibrand Poppema +5 more
TL;DR: The shift from a predominantly portal-based process toward lobular graft damage represents the early transition of AR to CR, for which a modification of immunosuppression might be necessary to prevent graft loss.
40
Prognostic factors for long-term actual patient survival after orthotopic liver transplantation in children.
Egbert Sieders,Pmjg Peeters,EM TenVergert,de Koert Jong,Robert J. Porte,JH Zwaveling,Cma Bijleveld,Mjh Slooff +7 more
TL;DR: Children with diseases eligible for liver transplantation should be seen early in the course of their disease in a transplantation center to keep the blood loss at a minimum and the choice of donors has implications for survival.
32
End-stage liver disease as the only consequence of a mitochondrial respiratory chain deficiency: no contra-indication for liver transplantation.
Jan Peter Rake,van FrancJan Spronsen,Gepke Visser,Wim Ruitenbeek,Joachim J. Schweizer,Cma Bijleveld,Pmjg Peeters,de Koert Jong,Mjh Slooff,Dirk Reijngoud,Klaziena Niezen-Koning,Gerrit Smit +11 more
TL;DR: Liver transplantation is a therapeutic option in mitochondrial respiratory chain deficiency-based end-stage liver disease provided that extra-hepatic involvement is carefully excluded, provided that the enzyme defect is localised in the liver.
28